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The presence of a systemic inflammatory response predicted cancer-specific (HR 2.55, 95% CI 1.22–5.32, Po0.05) and overall
survival (HR 2.12, 95% CI 1.17–3.87, Po0.05), independent of Dukes stage, in patients who had undergone apparently curative
surgery for colorectal cancer (n¼158). Deprivation predicted overall survival (HR 1.26, 95% CI 1.04–1.51, Po0.05) independent of
Dukes stage.
British Journal of Cancer (2003) 89, 612–614. doi:10.1038/sj.bjc.6601156 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: colorectal cancer; deprivation; the systemic inflammatory response; C-reactive protein; survival
                          
There is evidence that, in a variety of tumour types, deprivation is
associated with poor outcome. For example, in colorectal cancer
there is a 5% survival difference between the most and least
affluent members of society (Coleman et al, 1999). The basis of the
difference in outcome according to socioeconomic status has not
been clearly defined. It has been suggested that deprived patients
have less access to health care and as a consequence present with
more advanced disease and receive less-effective treatment
(Kogevinas and Porta, 1997; Coleman et al, 1999). Detailed
information on stage at diagnosis, type of surgery and subsequent
treatment was not included in the above analyses.
However, in a recent analysis of outcome in over 2000 patients
undergoing surgery for colorectal cancer, there was no evidence
that mode or stage at presentation, the proportion of patients
undergoing curative resection or postoperative mortality ac-
counted for the difference in survival between the affluent and
deprived patients (Hole and McArdle, 2002). After adjustment for
the above factors, there was a 36 and 26% excess risk of overall and
cancer-specific death, respectively, in the most deprived following
curative resection. Therefore, it would appear that neither stage of
disease at presentation nor variations in treatment are responsible
for the difference in survival between the affluent and deprived.
Disease progression is a complex process that depends on a
series of interactions between tumour and host cells. It is not only
the intrinsic properties of tumour cells that determine invasion
and metastasis, but also the environment in which malignant cells
find themselves (Balkwill and Mantovani, 2001). Therefore, an
alternative hypothesis to explain the effect of deprivation on
outcome following curative resection for colorectal cancer is that
the tumour–host response in the most deprived patients is altered.
One aspect of the host response that has recently generated
interest is the nonspecific systemic inflammatory response which
is recognised to be associated with primary operable colorectal
cancer. Indeed, there is evidence that the systemic inflammatory
response (as evidenced by C-reactive protein) predicts recurrence
(McMillan et al, 1995), overall (Nielsen et al, 2000; McMillan et al,
2003) and cancer-specific (McMillan et al, 2003) survival,
independent of stage, in patients who have undergone curative
resection for colorectal cancer.
The aim of the present study was to examine the relationship
between deprivation, the systemic inflammatory response and
survival in patients who had undergone curative resection for
colorectal cancer.
PATIENTS AND METHODS
One hundred and fifty-eight patients with histologically proven
colorectal cancer who, on the basis of laparotomy findings and
preoperative abdominal computed tomography, were considered
to have undergone curative resection between 1993 and 1999 in a
single surgical unit at Glasgow Royal Infirmary were included in
the study. Prior to surgery, a blood sample was taken for the
measurement of C-reactive protein. At this time no patient showed
clinical evidence of tumour recurrence, infection or other
inflammatory conditions. The tumours were staged using conven-
tional Dukes’ classification (Dukes and Bussey, 1958).
The extent of deprivation was defined using the Carstairs
deprivation index (Carstairs and Morris, 1991). This is an area-
based measure derived from the 1991 census, using the postcode of
residence at diagnosis, which divides the score into a seven-point
index. For illustrative purposes, the results are presented by
amalgamating the seven categories into three groups: affluent
(categories 1 and 2), intermediate (categories 3–5) and deprived
(categories 6 and 7). The Carstairs deprivation index has been
extensively utilised in cancer patients (Edwards and Jones, 1999)
and is particularly appropriate for use in the central belt of
Scotland (MacKie and Hole, 1996).
The study was approved by the Research Ethics Committee of
the Royal Infirmary, Glasgow, UK.
C-reactive protein was measured by Fluorescence Polarisation
Immunoassay using an Abbott TDX analyser and Abbott reagents
(Abbott Laboratories, Abbott Park, IL, USA). The limit of detection Received 8 October 2002; revised 9 May 2003; accepted 25 May 2003
*Correspondence: Dr DC McMillan;
E-mail: d.c.mcmillan@clinmed.gla.ac.uk
British Journal of Cancer (2003) 89, 612–614
& 2003 Cancer Research UK All rights reserved 0007– 0920/03 $25.00
www.bjcancer.com
C
l
i
n
i
c
a
lof the assay is a C-reactive protein concentration of less than
5mgl
 1. The coefficient of variation, over the range of measure-
ment, was less than 5% as established by routine quality control
procedures.
Statistics
Data are presented as median and range. Based on previous work,
a C-reactive protein concentration of greater than 10mgl
 1 was
considered to indicate the presence of a systemic inflammatory
response.
Survival analysis was performed using the Cox proportional
hazard model with patients’ age, sex, tumour site, Dukes stage,
deprivation index and C-reactive protein as prognostic variables.
Deaths up to the end of June 2002 have been included in the
analysis. Multivariate survival analysis was performed using a
stepwise backward procedure to derive a final model of the
variables that had a significant independent relationship with
survival. To remove a variable from the model, the corresponding
P-value had to be greater than 0.10. Analysis was performed using
SPSS software (SPSS Inc., Chicago, IL, USA).
RESULTS
Baseline characteristics of the patients (n¼158) who underwent
curative surgery for colorectal cancer are shown in Table 1. Three
percent of the patients were affluent and 56% were deprived.
Twenty-two patients received adjuvant 5-fluorouracil-based che-
motherapy.
The minimum follow-up was 30 months and the median follow-
up was 49 months. During this period, 50 patients died, 32 patients
of their cancer and 18 of intercurrent disease, and seven of
cardiovascular disease.
Cancer-specific survival: On univariate analysis, age, Dukes stage
and C-reactive protein concentration were predictors of cancer-
specific survival (Table 2). On multivariate analysis, age
(Po0.001), Dukes stage (Pp0.01) and C-reactive protein concen-
tration (Po0.05) retained independent significance.
Overall survival: On univariate analysis, age, deprivation, Dukes
stage and C-reactive protein concentration were significant
predictors of overall survival (Table 3). On multivariate analysis,
age (Po0.001), deprivation (Po0.05), Dukes stage (Pp0.001) and
C-reactive protein concentration (Po0.05) all retained indepen-
dent significance.
DISCUSSION
In the present study, we examined a homogenous group of patients
who had undergone potentially curative resection. More than half
of the patients belonged to the most deprived category. This is not
surprising since eight of the 15 most deprived areas in the UK are
in Glasgow (Gordon et al, 1999). As a result, the population served
by Glasgow Royal Infirmary provide an ideal cohort of patients in
whom to study the effect of deprivation.
On univariate and multivariate analyses, age, Dukes stage
and the systemic inflammatory response were significant
independent predictors of cancer-specific survival. This is
consistent with the results of previous studies that indicate that
the presence of a systemic inflammatory response is a significant
predictor of cancer-specific survival, independent of Dukes stage,
in patients undergoing apparently curative surgery for colorectal
cancer. In contrast, deprivation failed to achieve statistical
significance. This would suggest that the impact of deprivation
on cancer-specific survival is less than that of the systemic
inflammatory response.
The mechanism by which the presence of a systemic inflamma-
tory response might influence cancer-specific survival is not clear.
However, it is known that as part of the systemic inflammatory
response to the tumour there is a release of proinflammatory
cytokines and growth factors, some of which may promote tumour
growth (Moldawer and Copeland, 1997) and hence influence
survival. Furthermore, given that C-reactive protein concentra-
tions are primarily determined by interleukin-6 concentrations, it
is of interest that recent studies have shown that increased
circulating concentrations of interleukin-6 in colorectal cancer are
related to its production by the tumour (Kinoshita et al, 1999). It
Table 1 Characteristics of patients who underwent curative resection
for colorectal cancer
Patients (n¼158)
Age group (years)
o65 45 (29%)
65–74 53 (33%)
75+ 60 (38%)
Sex
Male 80 (51%)
Female 78 (49%)
Deprivation index
1, 2 4 (3%)
3, 4, 5 65 (41%)
6, 7 89 (56%)
Tumour site
Colon 109 (69%)
Rectum 49 (31%)
Dukes stage
B 99 (63%)
C 59 (37%)
Adjuvant therapy 22 (14%)
Table 2 Relationship between variables and cancer-specific survival following curative resection for
colorectal cancer
Univariate analysis Multivariate analysis
Hazard ratio (95% CI) (P-value) Hazard ratio (95% CI) (P-value)
Age
(o65/65–74/475 years) 2.72 (1.62–4.56) o0.001 2.58 (1.56–4.27) o0.001
Sex (male/female) 0.506 0.685
Deprivation index (1–7) 0.420 0.354
Tumour site
(colon/rectum) 0.311 0.281
Dukes stage (B/C) 2.28 (1.14–4.57) 0.019 2.57 (1.25–5.26) 0.010
Adjuvant therapy (yes/no) 0.803 0.941
C-reactive protein
(p10/410mgl
 l) 2.13 (1.05–4.32) 0.037 2.55 (1.22–5.32) 0.013
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response is a reflection of the malignant potential of the tumour.
On univariate and multivariate analysis, deprivation, Dukes
stage and the systemic inflammatory response were significant
independent predictors of overall survival. These results are
therefore consistent with previous studies showing an association
between deprivation and overall survival (Kogevinas and Porta,
1997; Hole and McArdle, 2002), and the presence of a systemic
inflammatory response and overall survival (Nozoe et al, 1998;
Nielsen et al., 2000) in patients undergoing apparently curative
surgery for colorectal cancer.
It was of interest that deprivation achieved significance as a
predictor of overall survival but not cancer-specific survival. This
was because approximately one-third of deaths were due to
intercurrent disease, most commonly cardiovascular disease.
However, the mechanism by which deprivation impacts on overall
survival is also not clear.
Although deprivation has been shown to be associated with
increased comorbidity in cancer patients (Schrijvers et al, 1997),
the relationship between deprivation, the presence of a systemic
inflammatory response and death from intercurrent disease in
patients with cancer remains to be established. However, obesity
and smoking, which are associated with deprivation, are known to
be associated with the presence of a systemic inflammatory
response (Keonig et al, 1999). Furthermore, there is increasing
evidence that the presence of a systemic inflammatory response is
associated with increased risk of death from cardiovascular disease
(Danesh et al, 2000).
In summary, the presence of the systemic inflammatory
response contributes to poorer cancer-specific survival of patients
who have undergone apparently curative surgery for colorectal
cancer. Both deprivation and the presence of a systemic
inflammatory response appear to contribute to overall survival.
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